Oral edaravone was approved in 2022 based on bioequivalence and long-term safety studies comparing it with the IV edaravone ...

SAVANNAH, Ga. -- One year after starting efgartigimod (Vyvgart) treatment, most generalized myasthenia gravis (gMG) patients ...

Weiss highlighted a 2012 Cochrane Library review that examined research and found the drug is “reasonably safe” and prolongs ...

The fellows are encouraged to be involved in a clinical research study. Detailed conferences in neuromuscular and electrodiagnostic medicine are held weekly. Neuromuscular medicine faculty includes: ...

SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder ...

Delandistrogene moxeparvovec (Elevidys), a gene therapy approved to treat Duchenne muscular dystrophy, missed its primary ...

The University of Alabama at Birmingham (UAB) provides an ACGME accredited, one year, neuromuscular medicine fellowship program. Our fellowship offers comprehensive training in clinical neuromuscular ...

Johnson & Johnson has burnished the evidence for nipocalimab, adding a sliver of data in adolescents with generalized ...

Tuesday announced positive topline data from the Phase 3 MINT study evaluating Uplizna for the treatment of adults ...

Investigational nipocalimab lessened disease severity in generalized myasthenia gravis (gMG), the phase III Vivacity-MG3 ...

Alexion to present data from its leading generalised myasthenia gravis portfolio at 2024 AANEM annual meeting: Cambridge, UK Friday, October 11, 2024, 13:30 Hrs [IST] Alexion, Ast ...